Growth Metrics

ADC Therapeutics (ADCT) EPS (Weighted Average and Diluted) (2020 - 2026)

ADC Therapeutics has reported EPS (Weighted Average and Diluted) over the past 7 years, most recently at -$0.21 for Q1 2026.